Phase I Study of Adenoviral Delivery of the HSV-tk Gene and Ganciclovir Administration in Patients with Recurrent Malignant Brain Tumors
Open Access
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier in Molecular Therapy
- Vol. 1 (2) , 195-203
- https://doi.org/10.1006/mthe.2000.0030
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Molecular Evaluation of Biopsy and Autopsy Specimens from Patients Receiving in Vivo Retroviral Gene TherapyHuman Gene Therapy, 1999
- Evaluation of an E1E4-Deleted Adenovirus Expressing the Herpes Simplex Thymidine Kinase Suicide Gene in Cancer Gene TherapyHuman Gene Therapy, 1999
- Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-γ, interleukin-7, or B7-1-transfected tumor cellsCancer Gene Therapy, 1999
- Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumorsGene Therapy, 1998
- β-Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and AdenovirusesHuman Gene Therapy, 1998
- Adeno-associated Virus Vector Containing the Herpes Simplex Virus Thymidine Kinase Gene Causes Complete Regression of Intracerebrally Implanted Human Gliomas in Mice, in Conjunction with Ganciclovir AdministrationJapanese Journal of Cancer Research, 1998
- Intracranial Administration of Adenovirus Expressing HSV-TK in Combination with Ganciclovir Produces a Dose-Dependent, Self-Limiting Inflammatory ResponseHuman Gene Therapy, 1997
- Adenoviral-Mediated Thymidine Kinase Gene Transfer into the Primate Brain Followed by Systemic Ganciclovir: Pathologic, Radiologic, and Molecular StudiesHuman Gene Therapy, 1996
- Adenovirus‐mediated gene therapy of experimental gliomasJournal of Neuroscience Research, 1994
- The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in ratsJournal of Neurosurgery, 1994